Instituto Rosenbusch

Instituto Rosenbusch EBIT per Employee

EBIT per Employee of Instituto Rosenbusch (ROSE2.BA) as of Oct 17, 2026.

EBIT per Employee

-ARS

Last updated:

EBIT per Employee of Instituto Rosenbusch is 2026 - ARS. EBIT per Employee of Instituto Rosenbusch was 2025 - ARS. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instituto Rosenbusch Stock analysis

What does Instituto Rosenbusch do? Instituto Rosenbusch SA, based in Buenos Aires, Argentina, operates in the Health Care sector, specifically in Pharmaceuticals. The company manufactures and markets veterinary products, including pharmaceuticals such as antibiotics, antimastitics, antimycotics, antiparasites, vitamins, and minerals, as well as biological products like vaccines for cattle, equines, pigs, sheep, and dogs. It also engages in meat slaughtering and provision. Listed on 21 February 2008, the company owns subsidiaries including Laboratorios Rosenbusch SA, Laboratorios Bolivar SA, and Rosenbusch Paraguay SA. Instituto Rosenbusch is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instituto Rosenbusch stock

On Eulerpool you can find the complete historical development of EBIT per Employee Instituto Rosenbusch since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's ARS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Instituto Rosenbusch historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Instituto Rosenbusch

All Key Metrics — Instituto Rosenbusch